Renovaro Biosciences (RENB) Q4 2023 Earnings

Feb 14Confirmed
Q1 2022
Q4 2022
Q1 2023
Q4 2023
-1.7
-1.13
-0.57
0

Details

Expected EPS
N/A
Actual EPS
-0.07
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Renovaro Biosciences⁩ (⁦RENB⁩) has reported earnings of ⁦-0.07⁩ per share for ⁦Q4 2023⁩.

0 Comments

Share your thoughts